Mingyue Optical LensLtd Past Earnings Performance
Past criteria checks 3/6
Mingyue Optical LensLtd has been growing earnings at an average annual rate of 24.3%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 9.5% per year. Mingyue Optical LensLtd's return on equity is 11%, and it has net margins of 22.4%.
Key information
24.3%
Earnings growth rate
15.9%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | 9.5% |
| Return on equity | 11.0% |
| Net Margin | 22.4% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Concerns Surrounding Mingyue Optical LensLtd's (SZSE:301101) Performance
Nov 01
We Think You Should Be Aware Of Some Concerning Factors In Mingyue Optical LensLtd's (SZSE:301101) Earnings
May 01Recent updates
Optimistic Investors Push Mingyue Optical Lens Co.,Ltd. (SZSE:301101) Shares Up 39% But Growth Is Lacking
Nov 27Mingyue Optical Lens Co.,Ltd.'s (SZSE:301101) 39% Share Price Surge Not Quite Adding Up
Nov 27Concerns Surrounding Mingyue Optical LensLtd's (SZSE:301101) Performance
Nov 01Mingyue Optical LensLtd (SZSE:301101) May Have Issues Allocating Its Capital
Sep 30Mingyue Optical Lens Co.,Ltd.'s (SZSE:301101) Shares Climb 36% But Its Business Is Yet to Catch Up
Aug 26Mingyue Optical Lens Co.,Ltd.'s (SZSE:301101) Earnings Are Not Doing Enough For Some Investors
Jun 21Mingyue Optical LensLtd's (SZSE:301101) Dividend Will Be CN¥0.30
May 24We Think You Should Be Aware Of Some Concerning Factors In Mingyue Optical LensLtd's (SZSE:301101) Earnings
May 01Mingyue Optical LensLtd (SZSE:301101) Will Want To Turn Around Its Return Trends
Apr 12Mingyue Optical Lens Co.,Ltd.'s (SZSE:301101) Popularity With Investors Is Under Threat From Overpricing
Mar 05Revenue & Expenses Breakdown
How Mingyue Optical LensLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 769 | 172 | 232 | 34 |
| 30 Jun 24 | 768 | 166 | 242 | 31 |
| 31 Mar 24 | 769 | 165 | 238 | 29 |
| 31 Dec 23 | 749 | 158 | 226 | 28 |
| 30 Sep 23 | 731 | 171 | 219 | 24 |
| 30 Jun 23 | 703 | 164 | 197 | 25 |
| 31 Mar 23 | 658 | 149 | 183 | 23 |
| 01 Jan 23 | 623 | 136 | 176 | 22 |
| 30 Sep 22 | 620 | 115 | 170 | 20 |
| 30 Jun 22 | 590 | 100 | 174 | 18 |
| 31 Mar 22 | 592 | 91 | 183 | 18 |
| 01 Jan 22 | 576 | 82 | 184 | 18 |
| 30 Sep 21 | 576 | 87 | 323 | 31 |
| 30 Jun 21 | 565 | 83 | 182 | 19 |
| 31 Mar 21 | 536 | 72 | 179 | 18 |
| 31 Dec 20 | 540 | 70 | 181 | 17 |
| 30 Sep 20 | 537 | 64 | 162 | 16 |
| 31 Dec 19 | 553 | 70 | 161 | 16 |
| 31 Dec 18 | 509 | 33 | 145 | 15 |
| 31 Dec 17 | 426 | 17 | 113 | 15 |
Quality Earnings: 301101 has high quality earnings.
Growing Profit Margin: 301101's current net profit margins (22.4%) are lower than last year (23.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 301101's earnings have grown significantly by 24.3% per year over the past 5 years.
Accelerating Growth: 301101's earnings growth over the past year (0.4%) is below its 5-year average (24.3% per year).
Earnings vs Industry: 301101 earnings growth over the past year (0.4%) exceeded the Medical Equipment industry -8.8%.
Return on Equity
High ROE: 301101's Return on Equity (11%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 17:13 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Mingyue Optical Lens Co.,Ltd. is covered by 11 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bairu Chen | China Galaxy Securities Co., Ltd. |
| Junhao Fan | China International Capital Corporation Limited |
| Zhuonan Xu | China International Capital Corporation Limited |